Daniel Ford

913 total citations
31 papers, 633 citations indexed

About

Daniel Ford is a scholar working on Nephrology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daniel Ford has authored 31 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 6 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniel Ford's work include Dialysis and Renal Disease Management (8 papers), Renal and Vascular Pathologies (5 papers) and Healthcare Policy and Management (4 papers). Daniel Ford is often cited by papers focused on Dialysis and Renal Disease Management (8 papers), Renal and Vascular Pathologies (5 papers) and Healthcare Policy and Management (4 papers). Daniel Ford collaborates with scholars based in United Kingdom, United States and Australia. Daniel Ford's co-authors include David Ansell, Charles Tomson, Retha Steenkamp, Paul Roderick, Stephanie MacNeill, John Porter, Richard J. Payne, Julie Gilg, Ian Whitcombe and James M. A. Turner and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Daniel Ford

31 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Ford United Kingdom 14 204 160 101 88 70 31 633
Hugh Cairns United Kingdom 18 441 2.2× 102 0.6× 102 1.0× 373 4.2× 68 1.0× 59 1.2k
Lalita Subramanian United States 17 209 1.0× 277 1.7× 14 0.1× 49 0.6× 23 0.3× 27 840
Li‐Ju Lin Taiwan 14 54 0.3× 177 1.1× 40 0.4× 36 0.4× 38 0.5× 41 605
Jackie McDonald United States 10 185 0.9× 273 1.7× 20 0.2× 42 0.5× 8 0.1× 15 783
Lynne Yao United States 17 247 1.2× 217 1.4× 8 0.1× 57 0.6× 100 1.4× 56 1.2k
Shinichiro Tsuchiya Japan 16 358 1.8× 296 1.9× 103 1.0× 260 3.0× 5 0.1× 57 793
Robert Heggie United Kingdom 13 17 0.1× 46 0.3× 78 0.8× 41 0.5× 64 0.9× 34 454
Lorna Duncan United Kingdom 19 23 0.1× 375 2.3× 28 0.3× 81 0.9× 181 2.6× 39 1.1k
Harleen Singh United States 10 39 0.2× 65 0.4× 23 0.2× 45 0.5× 26 0.4× 29 538
Pol Boudes United States 16 105 0.5× 140 0.9× 150 1.5× 102 1.2× 16 0.2× 58 768

Countries citing papers authored by Daniel Ford

Since Specialization
Citations

This map shows the geographic impact of Daniel Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Ford more than expected).

Fields of papers citing papers by Daniel Ford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Ford. The network helps show where Daniel Ford may publish in the future.

Co-authorship network of co-authors of Daniel Ford

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Ford. A scholar is included among the top collaborators of Daniel Ford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Ford. Daniel Ford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gannon, Whitney D., Melissa A. Vogelsong, Matthew Bacchetta, et al.. (2025). Low-Intensity vs Moderate-Intensity Anticoagulation for Venovenous Extracorporeal Membrane Oxygenation. CHEST Journal. 168(3). 639–649. 1 indexed citations
2.
Ford, Daniel, Simona Angerani, Imala Alwis, et al.. (2024). Development of supramolecular anticoagulants with on-demand reversibility. Nature Biotechnology. 43(2). 186–193. 12 indexed citations
3.
Ullrich, Sven, Rebecca L. Frkic, Anupriya Aggarwal, et al.. (2022). Antiviral cyclic peptides targeting the main protease of SARS-CoV-2. Chemical Science. 13(13). 3826–3836. 45 indexed citations
4.
Ford, Daniel, Jorge Ripoll‐Rozada, Stijn M. Agten, et al.. (2021). Potent Cyclic Peptide Inhibitors of FXIIa Discovered by mRNA Display with Genetic Code Reprogramming. Journal of Medicinal Chemistry. 64(11). 7853–7876. 14 indexed citations
5.
Corcilius, Leo, Daniel Ford, Charlotte Franck, et al.. (2021). Late-stage modification of peptides and proteins at cysteine with diaryliodonium salts. Chemical Science. 12(42). 14159–14166. 16 indexed citations
6.
Ford, Daniel, Julie Gilg, & Andrew J Williams. (2017). UK Renal Registry 19th Annual Report: Chapter 7 Haemoglobin, Ferritin and Erythropoietin amongst UK Adult Dialysis Patients in 2015: National and Centre-specific Analyses. ˜The œNephron journals/Nephron journals. 137(1). 165–188. 3 indexed citations
7.
MacNeill, Stephanie & Daniel Ford. (2017). UK Renal Registry 19th Annual Report: Chapter 2 UK Renal Replacement Therapy Prevalence in 2015: National and Centre-specific Analyses. ˜The œNephron journals/Nephron journals. 137(1). 45–72. 20 indexed citations
8.
Ansell, David, Yoav Ben‐Shlomo, Daniel Ford, Paul Roderick, & Charles Tomson. (2011). Appendix E: Methodology for Estimating Catchment Populations of Renal Centres in England for Dialysis Patients. Nephron Clinical Practice. 119(s2). c293–c295. 1 indexed citations
9.
Goyal, Madhav, Jennifer A. Haythornthwaite, David M. Levine, et al.. (2010). Intensive Meditation for Refractory Pain and Symptoms. The Journal of Alternative and Complementary Medicine. 16(6). 627–631. 19 indexed citations
10.
Donovan, K., et al.. (2010). International comparisons with the UK RRT programme.. Nephron. 115. 4 indexed citations
11.
Ford, Daniel, et al.. (2010). Chapter 3: UK ESRD Incident Rates in 2008: national and centre-specific analyses. Nephron Clinical Practice. 115(1). c9–c40. 33 indexed citations
12.
Ford, Daniel, Damian Fogarty, Retha Steenkamp, et al.. (2010). Chapter 13: The UK Renal Registry Advanced CKD Study: frequency of incorrect reporting of date of start of RRT. Nephron Clinical Practice. 115(1). c271–c278. 13 indexed citations
13.
Donovan, Kieron, et al.. (2010). Chapter 16: International Comparisons with the UK RRT Programme. Nephron Clinical Practice. 115(1). c309–c320. 15 indexed citations
14.
15.
Porter, John, Andrew Payne, Ian Whitcombe, et al.. (2009). Atropisomeric small molecule Bcl-2 ligands: Determination of bioactive conformation. Bioorganic & Medicinal Chemistry Letters. 19(6). 1767–1772. 28 indexed citations
16.
Williams, Andrew J, Daniel Ford, Anna Casula, & Charles Tomson. (2009). UK Renal Registry 11th Annual Report (December 2008): Chapter 8 Adequacy of haemodialysis in UK renal centres in 2007: national and centre-specific analyses. Nephron Clinical Practice. 111(1). c141–c147. 2 indexed citations
17.
18.
Harper, Janice, Johann Nicholas, Daniel Ford, Anna Casula, & Andrew J Williams. (2009). UK Renal Registry 11th Annual Report (December 2008): Chapter 11 Blood pressure profile of prevalent patients receiving dialysis in the UK in 2007: national and centre-specific analyses. Nephron Clinical Practice. 111(1). c227–c245. 7 indexed citations
19.
Porter, John, Andrew Payne, Daniel Ford, et al.. (2008). Tetrahydroisoquinoline amide substituted phenyl pyrazoles as selective Bcl-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(1). 230–233. 86 indexed citations
20.
Phillips, Sally, R.C. Cantrill, Daniel Ford, & Duncan Mitchell. (1986). Microinjection of dopamine agonists into nucleus raphe magnus affects nociception in rats. Pain. 26(2). 259–266. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hugh Cairns Breakdown of academic impact, for papers by Lalita Subramanian Breakdown of academic impact, for papers by Li‐Ju Lin Breakdown of academic impact, for papers by Jackie McDonald Breakdown of academic impact, for papers by Lynne Yao Breakdown of academic impact, for papers by Shinichiro Tsuchiya Breakdown of academic impact, for papers by Robert Heggie Breakdown of academic impact, for papers by Lorna Duncan Breakdown of academic impact, for papers by Harleen Singh Breakdown of academic impact, for papers by Pol Boudes
Rankless by CCL
2026